BCL2L1 and lung cancer: In a Kras(G12D/WT); p53(Frt/Frt) model of lung cancer, blocking Bcl-xL activity impairs TAN ageing, thus diminishing the abundance of long-lived, tumor-supportive TANs, while preserving young TANs.